BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 7630623)

  • 1. Comparative study on topical and oral administration of ofloxacin for Pseudomonas corneal ulcer in rabbits.
    Shiao S; Isobe Y; Hatano H; Ohno S
    Ophthalmologica; 1995; 209(3):155-9. PubMed ID: 7630623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of experimental bacterial keratitis with topical trovafloxacin.
    Barequet IS; Denton P; Osterhout GJ; Tuli S; O'Brien TP
    Arch Ophthalmol; 2004 Jan; 122(1):65-9. PubMed ID: 14718297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM
    Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of ophthalmic gatifloxacin 0.3% and ciprofloxacin 0.3% in healing of corneal ulcers associated with Pseudomonas aeruginosa-induced ulcerative keratitis in rabbits.
    Jensen H; Zerouala C; Carrier M; Short B
    J Ocul Pharmacol Ther; 2005 Feb; 21(1):36-43. PubMed ID: 15718826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed-onset Pseudomonas keratitis after radial keratotomy.
    Procope JA
    J Cataract Refract Surg; 1997 Oct; 23(8):1271-2. PubMed ID: 9368176
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of pseudomonal ulceration in rabbit corneas by a synthetic matrix metalloproteinase inhibitor.
    Barletta JP; Angella G; Balch KC; Dimova HG; Stern GA; Moser MT; van Setten GB; Schultz GS
    Invest Ophthalmol Vis Sci; 1996 Jan; 37(1):20-8. PubMed ID: 8550324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Povidone-iodine (betadine) in the treatment of experimental Pseudomonas aeruginosa keratitis.
    Michalová K; Moyes AL; Cameron S; Juni BA; Obritsch WF; Dvorak JA; Doughman DJ; Rhame FS
    Cornea; 1996 Sep; 15(5):533-6. PubMed ID: 8862931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of invasive and cytotoxic Pseudomonas aeruginosa strain-induced corneal disease responses to therapeutics.
    Lee EJ; Truong TN; Mendoza MN; Fleiszig SM
    Curr Eye Res; 2003 Nov; 27(5):289-99. PubMed ID: 14562165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin-enmeshed tobramycin liposomes: single application topical therapy of Pseudomonas keratitis.
    Frucht-Perry J; Assil KK; Ziegler E; Douglas H; Brown SI; Schanzlin DJ; Weinreb RN
    Cornea; 1992 Sep; 11(5):393-7. PubMed ID: 1424666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical levofloxacin 1.5% overcomes in vitro resistance in rabbit keratitis models.
    Kowalski RP; Romanowski EG; Mah FS; Shanks RM; Gordon YJ
    Acta Ophthalmol; 2010 Jun; 88(4):e120-5. PubMed ID: 20456251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Collagen shields containing tobramycin for sustained therapy (24 hours) of experimental Pseudomonas keratitis.
    Clinch TE; Hobden JA; Hill JM; O'Callaghan RJ; Engel LS; Kaufmann HE
    CLAO J; 1992 Oct; 18(4):245-7. PubMed ID: 1424060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of systemic tetracycline on progression of Pseudomonas aeruginosa keratitis in the rabbit.
    Levy JH; Katz HR
    Ann Ophthalmol; 1990 May; 22(5):179-83. PubMed ID: 2114813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of Pseudomonas corneal infection related to orthokeratology.
    Araki-Sasaki K; Nishi I; Yonemura N; Takatsuka H; Mutoh K; Matsumoto K; Asari S; Tanihara H
    Cornea; 2005 Oct; 24(7):861-3. PubMed ID: 16160505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbiologic, Pharmacokinetic, and Clinical Effects of Corneal Collagen Cross-Linking on Experimentally Induced Pseudomonas Keratitis in Rabbits.
    Cosar CB; Kucuk M; Celik E; Gonen T; Akyar I; Serteser M; Tokat F; Ince U
    Cornea; 2015 Oct; 34(10):1276-80. PubMed ID: 26226468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enoxacin therapy for experimental pseudomonas keratitis.
    Esposito S; Thadepalli H; Benler HA; Chuah SK
    J Chemother; 1991 Jun; 3(3):147-51. PubMed ID: 1919652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topical norfloxacin therapy in Pseudomonas corneal ulceration.
    Vajpayee RB; Gupta SK; Angra SK; Munjal A
    Cornea; 1991 May; 10(3):268-71. PubMed ID: 2055033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of hybrid peptides of cecropin A and melittin in an experimental model of bacterial keratitis.
    Nos-Barbera S; Portoles M; Morilla A; Ubach J; Andreu D; Paterson CA
    Cornea; 1997 Jan; 16(1):101-6. PubMed ID: 8985641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Bacterial corneal ulcer treated with intrastromal antibiotic. Experimental model in vivo].
    Stangogiannis-Druya E; Stangogiannis-Druya C; Naranjo-Tackman R; Vanzzini V; Villar-KurĂ­ J
    Arch Soc Esp Oftalmol; 2009 Mar; 84(3):123-32. PubMed ID: 19340717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Doxycycline in the management of pseudomonas corneal melting: two case reports and a review of the literature.
    McElvanney AM
    Eye Contact Lens; 2003 Oct; 29(4):258-61. PubMed ID: 14555906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
    Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
    Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.